VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HCAT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HCATHealth Catalyst, Inc.
$1.96$145M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHCATQuarterly Financials

Health Catalyst, Inc. (HCAT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Health Catalyst, Inc. (HCAT) quarterly income statement — complete revenue, gross profit & net income history

HCAT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue70.76M74.68M76.32M80.72M79.41M79.61M76.35M75.9M74.72M75.08M73.77M73.21M
Revenue Growth %-10.9%-6.19%-0.04%6.35%6.28%6.02%3.5%3.67%1.16%8.56%7.93%3.65%
Cost of Goods Sold47.1M35.3M38.51M42.48M43.18M44.91M42.31M40.06M38.52M44.58M41.79M39.44M
COGS % of Revenue66.57%47.26%50.45%52.63%54.37%56.42%55.42%52.78%51.55%59.37%56.64%53.87%
Gross Profit23.66M39.38M37.82M38.24M36.23M34.69M34.04M35.84M36.21M30.51M31.99M33.77M
Gross Margin %33.43%52.74%49.55%47.37%45.63%43.58%44.58%47.22%48.45%40.63%43.36%46.13%
Gross Profit Growth %-34.71%13.53%11.09%6.69%0.08%13.71%6.42%6.12%1.81%-1.76%-0.09%-6.25%
Operating Expenses30.41M36.12M55.33M75.33M56.41M52.19M47.73M51.65M59.02M63.29M56.57M68.39M
OpEx % of Revenue42.97%48.37%72.49%93.33%71.03%65.56%62.51%68.05%78.98%84.3%76.68%93.42%
Selling, General & Admin24.55M13.33M30.43M21.49M28.9M26.92M23.55M27.11M33.62M32.7M26.92M40.07M
SG&A % of Revenue34.69%17.85%39.87%26.62%36.39%33.82%30.84%35.71%45%43.55%36.49%54.73%
Research & Development9.67M9.91M12.28M12.39M15.19M15M14.19M13.88M14.87M20.29M17.67M17.59M
R&D % of Revenue13.67%13.27%16.09%15.35%19.12%18.85%18.59%18.29%19.9%27.02%23.95%24.03%
Other Operating Expenses-1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income-6.75M3.26M-17.51M-37.09M-20.17M-17.5M-13.69M-15.81M-22.81M-32.78M-24.58M-34.62M
Operating Margin %-9.54%4.37%-22.94%-45.95%-25.4%-21.98%-17.93%-20.83%-30.53%-43.66%-33.32%-47.28%
Operating Income Growth %66.55%118.63%-27.92%-134.67%11.58%46.62%44.32%54.34%34.66%10.78%46.24%-4.3%
EBITDA5.37M16.14M-4.89M-24.41M-7.85M-7.23M-3.7M-5.15M-12.29M-22.48M-13.65M-23.88M
EBITDA Margin %7.59%21.62%-6.41%-30.24%-9.89%-9.09%-4.85%-6.79%-16.44%-29.94%-18.51%-32.62%
EBITDA Growth %168.36%323.15%-32.15%-373.98%36.1%67.82%72.87%78.44%46.94%7.52%58.05%-19.71%
D&A (Non-Cash Add-back)12.12M12.88M12.61M12.68M12.32M10.27M9.98M10.66M10.53M10.3M10.93M10.73M
EBIT-6.75M-85.13M-16.55M-35.11M-16.21M-12.75M-16.71M-11.61M-18.64M-28.34M-20.15M-30.71M
Net Interest Income-3.94M-4.61M-4.5M-4.13M-3.48M-2.45M-1.39M2.38M2.36M2.6M2.63M2.08M
Interest Income798K909K1.14M1.66M3.83M4.85M4.74M4.21M4.19M4.42M4.46M3.9M
Interest Expense4.74M5.52M5.63M5.79M7.32M7.3M6.13M1.83M1.83M1.83M1.82M1.82M
Other Income/Expense-103.86M-93.91M-4.68M-3.8M-3.36M-2.55M-1.51M2.36M2.34M2.62M2.61M2.09M
Pretax Income-110.61M-90.65M-22.19M-40.9M-23.53M-20.05M-15.2M-13.45M-20.47M-30.17M-21.97M-32.53M
Pretax Margin %-156.33%-121.38%-29.07%-50.66%-29.63%-25.18%-19.91%-17.71%-27.4%-40.18%-29.78%-44.43%
Income Tax414K379K41K81K215K625K-475K70K113K143K59K85K
Effective Tax Rate %-0.37%-0.42%-0.18%-0.2%-0.91%-3.12%3.12%-0.52%-0.55%-0.47%-0.27%-0.26%
Net Income-111.03M-91.03M-22.23M-40.98M-23.74M-20.67M-14.73M-13.52M-20.59M-30.31M-22.03M-32.61M
Net Margin %-156.91%-121.89%-29.12%-50.77%-29.9%-25.97%-19.29%-17.81%-27.55%-40.37%-29.86%-44.55%
Net Income Growth %-367.64%-340.31%-50.95%-203.18%-15.33%31.8%33.16%58.56%37.97%15.29%51.83%2.44%
Net Income (Continuing)-111.03M-91.03M-22.23M-40.98M-23.74M-20.67M-14.73M-13.52M-20.59M-30.31M-22.03M-32.61M
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)-1.53-1.28-0.32-0.59-0.35-0.33-0.24-0.23-0.35-0.53-0.39-0.58
EPS Growth %-337.14%-287.88%-33.33%-156.52%0%37.74%38.46%60.34%41.67%19.7%53.57%6.45%
EPS (Basic)-1.53-1.28-0.32-0.59-0.35-0.33-0.24-0.23-0.35-0.53-0.39-0.58
Diluted Shares Outstanding72.59M71M70.38M69.63M68.55M62.38M60.44M59.3M58.59M57.48M56.71M55.98M
Basic Shares Outstanding72.59M71M70.38M69.63M68.55M62.38M60.44M59.3M58.59M57.48M56.71M55.98M
Dividend Payout Ratio------------